INTERNATIONAL PATENT: INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA DE LA FUNDACION INSTITUTO CIENCIAS DE LA SALUD DE CASTILLA Y LEON, UNIVERSIDAD DE SALAMANCA FILES APPLICATION FOR "MED12 INHIBITOR, OR PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, FOR USE IN A METHOD FOR THE TREATMENT OF CANCER"

GENEVA, April 18 -- INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA DE LA FUNDACION INSTITUTO CIENCIAS DE LA SALUD DE CASTILLA Y LEON (Hospital Universitario de Salamanca, Edificio Virgen de la Vega, 10ª pl., Paseo San Vicente 58-18237007 Salamanca Salamanca), UNIVERSIDAD DE SALAMANCA (Patio de Escuelas, 137008 Salamanca Salamanca) filed a patent application (PCT/EP2025/079284) for "MED12 INHIBITOR, OR PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, FOR USE IN A METHOD FOR THE TREATMENT OF CANCER" on Oct 10, 2025. With publication no. WO/2026/078208, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, whi...